<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05014529</url>
  </required_header>
  <id_info>
    <org_study_id>202009223870</org_study_id>
    <nct_id>NCT05014529</nct_id>
  </id_info>
  <brief_title>The Continuous Positive Airway Pressure Effect on Rho-associated Coiled-coil Containing Kinases Activity.</brief_title>
  <official_title>The Continuous Positive Airway Pressure Effect on Rho-associated Coiled-coil Containing Kinases Activity and Left Ventricle Mass in Obstructive Sleep Apnea-hypopnea Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ROCK (Rho-associated coiled-coil containing kinases) play a critical role in the&#xD;
      pathogenesis of cardiovascular diseases and left ventricle hypertrophy (LVH). ROCK activity&#xD;
      can be used as a clinical biomarker for the diagnosis and monitoring of cardiovascular&#xD;
      disorders. Obstructive sleep apnea (OSA) increase cardiovascular disease and LVH. Continuous&#xD;
      positive airway pressure (CPAP) is the standard therapy for OSA. This study investigate the&#xD;
      effect of CPAP on ROCK activity and left ventricle mass.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ROCK were discovered as downstream targets of Ras homologous A and regulate various&#xD;
      important cellular functions, including proliferation, migration, adhesion, and apoptosis.&#xD;
      They play a critical role in the pathogenesis of cardiovascular diseases, including cardiac&#xD;
      fibrosis, hypertrophy, and remodeling. ROCK activity can be detected in human circulating&#xD;
      leukocytes and could potentially be used as a clinical biomarker for the diagnosis and&#xD;
      monitoring of cardiovascular disorders. It has been proven that higher ROCK activity is&#xD;
      present in left ventricle hypertrophy (LVH) patients than those without LVH. Obstructive&#xD;
      sleep apnea(OSA) is characterized by recurrent collapse of the pharyngeal airway during sleep&#xD;
      that leads to intermittent nocturnal hypoxia, resulting in a broad range of cardiovascular&#xD;
      morbidities, including coronary artery disease, heart failure, cardiac arrhythmias, and LVH.&#xD;
      Continuous positive airway pressure (CPAP) is the standard therapy for OSA and several&#xD;
      studies have shown that it can effectively reduce cardiovascular disease, but the effect of&#xD;
      CPAP on left ventricle mass reduction is still uncertain. Previous studies demonstrated that&#xD;
      patients with OSA had higher circulatory ROCK activity than those without OSA, but the role&#xD;
      of CPAP on ROCK activity is not known. The circulatory leukocyte ROCK activity may be used as&#xD;
      a clinical biomarker for cardiovascular disease and ROCK inhibitors may be used in the future&#xD;
      as a treatment. OSA and CPAP treatment may also affect ROCK activity, the relationship&#xD;
      between CPAP treatment, cardiac hypertrophy, and ROCK activity is important and should be&#xD;
      clarified. Therefore, the main purpose of our study is to evaluate the effect of CPAP on ROCK&#xD;
      activity and left ventricle mass.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ROCK activity</measure>
    <time_frame>Check baseline blood ROCK 1, ROCK 2, and MYTP-1 p/t and follow up these levels in six months later.</time_frame>
    <description>Compare the change of blood ROCK 1, ROCK 2, and MYTP-1 p/t (The levels of phosphorylated to total myosin light chain phosphatase 1) among those three groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricle mass</measure>
    <time_frame>Do baseline echocardiography and follow up echocardiography in six months later.</time_frame>
    <description>Compare the change left ventricle mass index among those three groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Obtain initial and blood pressure six months later.</time_frame>
    <description>Compare the blood pressure among those three groups.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Polysomography show AHI less than 15 events/h and participants do not receive any intervention include CPAP, oral appliance, or surgery for 6 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OSA without CPAP group</arm_group_label>
    <description>Polysomography show AHI greater than 15 events/h and participants do not receive any intervention include CPAP, oral appliance, or surgery for 6 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OSA with CPAP group</arm_group_label>
    <description>Polysomography show AHI greater than 15 events/h and participants receive CPAP more than 6 months.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum and blood leukocyte&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who have snoring or any other symptoms of sleep breathing disorders receive a&#xD;
        standard polysomnography study in the Chang Gung Sleep Center of Keelung.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        ‚óè Subjects who complete a standard polysomnography study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have heart failure (as determined by clinical symptoms or signs with&#xD;
             elevated brain natriuretic peptide and echocardiography showing structural or&#xD;
             functional abnormalities)&#xD;
&#xD;
          -  Coronary artery disease (stress electrocardiography, myocardial scintigraphy, or&#xD;
             coronary angiography proven coronary artery lesion)&#xD;
&#xD;
          -  Hypertrophic cardiomyopathy&#xD;
&#xD;
          -  Known infiltrative disease e.g. amyloidosis&#xD;
&#xD;
          -  Chronic kidney disease severe than stage III&#xD;
&#xD;
          -  Ischemic or hemorrhagic stroke&#xD;
&#xD;
          -  Central sleep apnea,&#xD;
&#xD;
          -  Hypoventilation syndrome (TCO2 or artery PaCO2 exceed 50 mmHg)&#xD;
&#xD;
          -  Unstable hemodynamic state&#xD;
&#xD;
          -  Eastern Cooperative Oncology Group Performance Status higher than grade 2&#xD;
&#xD;
          -  Pregnant women will be excluded.&#xD;
&#xD;
          -  Polysomnography exam showing sleep time less than 2 hours&#xD;
&#xD;
          -  Patients who receive surgery or oral appliance during the study period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sleep center</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang-Gung Memorial Hospital, Keelung</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chung-Chieh Yu, MD</last_name>
    <phone>886+22432-9292</phone>
    <phone_ext>2657</phone_ext>
    <email>terminatorchieh@yahoo.com.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ning-I Yang, MD</last_name>
    <phone>886+22431-3131</phone>
    <phone_ext>6203</phone_ext>
    <email>r3675@cgmh.org.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sleep center</name>
      <address>
        <city>Keelung</city>
        <zip>204</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Julian L, Olson MF. Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions. Small GTPases. 2014;5:e29846. doi: 10.4161/sgtp.29846. Epub 2014 Jul 10. Review.</citation>
    <PMID>25010901</PMID>
  </reference>
  <reference>
    <citation>Sekizuka H, Osada N, Akashi YJ. Impact of obstructive sleep apnea and hypertension on left ventricular hypertrophy in Japanese patients. Hypertens Res. 2017 May;40(5):477-482. doi: 10.1038/hr.2016.170. Epub 2016 Dec 1.</citation>
    <PMID>27904155</PMID>
  </reference>
  <reference>
    <citation>Stewart MH, Lavie CJ, Shah S, Englert J, Gilliland Y, Qamruddin S, Dinshaw H, Cash M, Ventura H, Milani R. Prognostic Implications of Left Ventricular Hypertrophy. Prog Cardiovasc Dis. 2018 Nov - Dec;61(5-6):446-455. doi: 10.1016/j.pcad.2018.11.002. Epub 2018 Nov 6. Review.</citation>
    <PMID>30408469</PMID>
  </reference>
  <reference>
    <citation>Zhang L, Zhuang JH, Peng H, Huang J, Huang LQ, Zhao ZX. Correlation between endothelial dysfunction, Rho-associated protein kinase activity, C-reactive protein and obstructive sleep apnoea syndrome in male patients. J Int Med Res. 2012;40(6):2183-90.</citation>
    <PMID>23321175</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 14, 2021</study_first_submitted>
  <study_first_submitted_qc>August 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>September 18, 2021</last_update_submitted>
  <last_update_submitted_qc>September 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chang Gung Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Chung-Chieh, Yu</investigator_full_name>
    <investigator_title>Director of Pulmonary Medicine Division</investigator_title>
  </responsible_party>
  <keyword>Continuous positive airway pressure</keyword>
  <keyword>Rho-associated coiled-coil containing kinases</keyword>
  <keyword>Left ventricle mass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Requestors need application and explain the purpose. The data access will be provided after approved by review panel.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

